Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as $0.31 and last traded at $0.31, with a volume of 0 shares trading hands. The stock had previously closed at $0.31.
Sino Biopharmaceutical Price Performance
The firm’s fifty day moving average is $0.36 and its two-hundred day moving average is $0.39.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection.
Featured Stories
- Five stocks we like better than Sino Biopharmaceutical
- How to Capture the Benefits of Dividend Increases
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Stock Market Upgrades: What Are They?
- Generac Powers Ahead on the Electrification Mega-Trend
- Best Stocks Under $5.00
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.